Physician profile
Amy Chen
NPI 1821738444
$1,585.53
in general payments reported to CMS, 2019-2025
13 companies · $580 in 2025
The $580 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $266 · 2024: $614 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,460.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $403.00 | 2023-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $272.48 | 2024-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $175.78 | 2024-2025 | Arexvy, Trelegy Ellipta |
| Si-Bone, INC. | $129.72 | 2023 | |
| Ucb, INC. | $124.96 | 2022 | |
| Novo Nordisk INC | $109.78 | 2024-2025 | Ozempic, Wegovy |
| Corcept Therapeutics | $85.08 | 2025 | Korlym |
| Exact Sciences Corporation | $64.15 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Shield Therapeutics INC | $53.55 | 2024-2025 | |
| Lilly USA, LLC | $51.18 | 2025 | Zepbound, Mounjaro |
| Eisai INC. | $49.81 | 2024-2025 | |
| Abbvie INC. | $41.75 | 2025 | |
| Amgen INC. | $24.29 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.